{"id":6724,"date":"2023-04-26T02:08:02","date_gmt":"2023-04-26T02:08:02","guid":{"rendered":"\/\/smallcapscn.x5view.co\/?p=6724"},"modified":"2023-08-29T17:57:42","modified_gmt":"2023-08-29T17:57:42","slug":"imugene-lifts-bank-balance-rebate-progress-immune-oncology-therapies","status":"publish","type":"post","link":"https:\/\/smallcapscn.x5view.co\/?p=6724","title":{"rendered":"Imugene\u4ee51260\u4e07\u6fb3\u5143\u7684\u56de\u6263\u63d0\u5347\u94f6\u884c\u4f59\u989d\uff0c\u7528\u4e8e\u53d1\u5c55\u514d\u75ab\u80bf\u7624\u7597\u6cd5"},"content":{"rendered":"<p>\u5728\u83b7\u5f97\u6fb3\u5927\u5229\u4e9a\u653f\u5e9c1260\u4e07\u6fb3\u5143\u7684\u7814\u53d1\u9000\u7a0e\u540e\uff0cImugene (ASX: IMU)\u6709\u4e86\u66f4\u591a\u7684\u73b0\u91d1\u6765\u7ee7\u7eed\u5176\u514d\u75ab\u80bf\u7624\u7597\u6cd5\u7684\u6301\u7eed\u5f00\u53d1\u3002<\/p>\n<p>\u6839\u636e\u653f\u5e9c\u7684\u7814\u7a76\u53ca\u53d1\u5c55\u7a0e\u52a1\u4f18\u60e0\u8ba1\u5212\uff0c\u4ece\u4e8b\u5408\u8d44\u683c\u6d3b\u52a8\u7684\u516c\u53f8\u53ef\u83b7\u5f97\u6700\u9ad8\u8fbe43.5%\u7684\u53ef\u9000\u8fd8\u7a0e\u6b3e\u62b5\u6263\u3002<\/p>\n<p>Imugene\u6b63\u5728\u5f00\u53d1\u764c\u75c7\u514d\u75ab\u7597\u6cd5\uff0c\u6709\u4e94\u4e2a\u4e3b\u8981\u8d44\u4ea7:HER-Vaxx\u3001CHECKvacc\u3001CF33-CD19\u3001VAXINIA\u548cPD1-Vaxx\u3002<\/p>\n<p>\u8be5\u4ea7\u54c1\u7ec4\u5408\u5305\u62ec\u6eb6\u7624\u75c5\u6bd2\u7597\u6cd5(VAXINIA\u6216CF33)\u3001\u591a\u79cdb\u7ec6\u80de\u5019\u9009\u75ab\u82d7\u548c\u65b0\u5174\u6280\u672f\uff0c\u5305\u62econCARlytics (CF33-CD19)\u4e0eCAR-T\u8054\u5408\uff0c\u6216\u9488\u5bf9\u5b9e\u4f53\u80bf\u7624\u7684\u9776\u5411CD19\u7684\u53cc\u7279\u5f02\u6027\u6297\u4f53\u3002<\/p>\n<p>\u8fd9\u4e9b\u7597\u6cd5\u65e8\u5728\u5229\u7528\u60a3\u8005\u7684\u514d\u75ab\u7cfb\u7edf\u6765\u5e2e\u52a9\u5176\u5bf9\u6297\u764c\u75c7\u3002<\/p>\n<p>\u4f5c\u4e3a\u5176\u4e2d\u7684\u4e00\u90e8\u5206\uff0cImugene\u6b63\u5728\u7814\u7a76\u5c06\u8fd9\u4e9b\u7597\u6cd5\u4f5c\u4e3a\u5355\u4e00\u7597\u6cd5(\u5355\u4e00\u7597\u6cd5)\u4ee5\u53ca\u4e0e\u5e02\u573a\u4e0a\u7684\u5176\u4ed6\u836f\u7269\u8054\u5408\u4f7f\u7528\u3002<\/p>\n<h2>\u6eb6\u7624\u7ec6\u80de\u7684\u75c5\u6bd2<\/h2>\n<p>2019\u5e74\uff0cImugene\u4eceCity of Hope\u7684Yuman Fong\u6559\u6388\u90a3\u91cc\u83b7\u5f97\u4e86CF33\u6eb6\u7624\u75c5\u6bd2\u5e73\u53f0\u7684\u8bb8\u53ef\u3002<\/p>\n<p>Fong\u6559\u6388\u662f\u8be5\u72ec\u7acb\u7814\u7a76\u673a\u6784\u5916\u79d1\u90e8\u95e8\u7684\u4e3b\u5e2d\u3002\u4ed6\u88ab\u63cf\u8ff0\u4e3a\u4e16\u754c\u77e5\u540d\u7684\u764c\u75c7\u7814\u7a76\u8005\u3001\u5185\u79d1\u533b\u751f\u548c\u5916\u79d1\u533b\u751f\u3002<\/p>\n<p>\u6eb6\u7624\u75c5\u6bd2\u57fa\u672c\u4e0a\u88ab\u8bbe\u8ba1\u6210\u53ea\u611f\u67d3\u548c\u6740\u6b7b\u764c\u7ec6\u80de\u3002\u75c5\u6bd2\u53ef\u4ee5\u8fdb\u4e00\u6b65\u88c5\u5907\u6709\u6548\u8f7d\u8377\uff0c\u4ee5\u63d0\u9ad8\u6740\u4f24\u80fd\u529b\u3002<\/p>\n<p>\u75c5\u6bd2\u8fdb\u5165\u764c\u7ec6\u80de\uff0c\u81ea\u6211\u590d\u5236\uff0c\u6700\u7ec8\u5bfc\u81f4\u7ec6\u80de\u7206\u70b8\u3002\u7136\u540e\uff0c\u6210\u5343\u4e0a\u4e07\u7684\u65b0\u75c5\u6bd2\u9897\u7c92\u91ca\u653e\u5230\u4f53\u5185\uff0c\u5b83\u4eec\u5c06\u5bfb\u627e\u5e76\u6467\u6bc1\u66f4\u591a\u7684\u764c\u7ec6\u80de\u3002<\/p>\n<h2>CHECKvacc<\/h2>\n<p>Imugene\u7684CHECKvacc\u662f\u4e00\u79cd\u6b66\u88c5\u75c5\u6bd2\uff0c\u7531CF33\u3001\u4eba\u7898\u5316\u94a0\u540c\u4f53(hNIS)\u548c\u6297\u4f53aPD-L1\u7ec4\u6210\u3002<\/p>\n<p>\u8fd9\u79cd\u6b66\u88c5\u75c5\u6bd2\u6b63\u7528\u4e8e\u8f6c\u79fb\u6027\u4e09\u9634\u6027\u4e73\u817a\u764c\u60a3\u8005\u7684\u4e00\u671f\u8bd5\u9a8c\u3002<\/p>\n<p>\u5728\u8fd9\u9879\u8bd5\u9a8c\u4e2d\uff0cCHECKvacc\u9776\u5411PD-L1\u86cb\u767d\u5e76\u6fc0\u6d3b\u5c40\u90e8\u80bf\u7624\u5fae\u73af\u5883\u3002<\/p>\n<p>\u4e0a\u5468\uff0c<a href=\"http:\/\/smallcaps-production.test\/imugene-positive-imaging-data-oncolytic-virotherapy-candidate-checkvacc\/?lang=cn\">Imugene\u62a5\u544a\u4e86CHECKvacc\u7684\u521d\u6b65\u9633\u6027\u6210\u50cf\u6570\u636e<\/a>\u3002<\/p>\n<p>\u521d\u6b65\u6210\u50cf\u6570\u636e\u663e\u793a\uff0c\u57281\u671f\u4e34\u5e8a\u8bd5\u9a8c\u4e2d\uff0c\u4e09\u4e2a\u961f\u5217\u7684\u4e09\u79cd\u5242\u91cf\u6c34\u5e73\u4e0b\uff0cCHECKvacc\u90fd\u5177\u6709\u201c\u826f\u597d\u7684\u8010\u53d7\u6027\u201d\u3002<\/p>\n<p>\u5ba1\u5224\u4ecd\u5728\u7ee7\u7eed\u3002<\/p>\n<p>\u5728\u4e34\u5e8a\u524d\u7814\u7a76\u4e2d\uff0cCHECKvacc\u663e\u793a\u51fa\u201c\u5f3a\u5927\u7684\u6297\u764c\u6d3b\u6027\u201d\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u5728\u83b7\u5f97\u6fb3\u5927\u5229\u4e9a\u653f\u5e9c1260\u4e07\u6fb3\u5143\u7684\u7814\u53d1\u9000\u7a0e\u540e\uff0cImugene (ASX: IMU)\u6709\u4e86\u66f4\u591a\u7684\u73b0\u91d1\u6765\u7ee7\u7eed\u5176\u514d\u75ab\u80bf\u7624\u7597\u6cd5\u7684\u6301\u7eed\u5f00\u53d1\u3002 \u6839\u636e\u653f\u5e9c\u7684\u7814\u7a76\u53ca\u53d1\u5c55\u7a0e\u52a1\u4f18\u60e0\u8ba1\u5212\uff0c\u4ece\u4e8b\u5408\u8d44\u683c\u6d3b\u52a8\u7684\u516c\u53f8\u53ef\u83b7\u5f97\u6700\u9ad8\u8fbe43.5%\u7684\u53ef\u9000\u8fd8\u7a0e\u6b3e\u62b5\u6263\u3002 Imugene\u6b63\u5728\u5f00\u53d1\u764c\u75c7\u514d\u75ab\u7597\u6cd5\uff0c\u6709\u4e94\u4e2a\u4e3b\u8981\u8d44\u4ea7:HER-Vaxx\u3001CHECKvacc\u3001CF33-CD19\u3001VAXINIA\u548cPD1-Vaxx\u3002 \u8be5\u4ea7\u54c1\u7ec4\u5408\u5305\u62ec\u6eb6\u7624\u75c5\u6bd2\u7597\u6cd5(VAXINIA\u6216CF33)\u3001\u591a\u79cdb\u7ec6\u80de\u5019\u9009\u75ab\u82d7\u548c\u65b0\u5174\u6280\u672f\uff0c\u5305\u62econCARlytics (CF33-CD19)\u4e0eCAR-T\u8054\u5408\uff0c\u6216\u9488\u5bf9\u5b9e\u4f53\u80bf\u7624\u7684\u9776\u5411CD19\u7684\u53cc\u7279\u5f02\u6027\u6297\u4f53\u3002 \u8fd9\u4e9b\u7597\u6cd5\u65e8\u5728\u5229\u7528\u60a3\u8005\u7684\u514d\u75ab\u7cfb\u7edf\u6765\u5e2e\u52a9\u5176\u5bf9\u6297\u764c\u75c7\u3002 \u4f5c\u4e3a\u5176\u4e2d\u7684\u4e00\u90e8\u5206\uff0cImugene\u6b63\u5728\u7814\u7a76\u5c06\u8fd9\u4e9b\u7597\u6cd5\u4f5c\u4e3a\u5355\u4e00\u7597\u6cd5(\u5355\u4e00\u7597\u6cd5)\u4ee5\u53ca\u4e0e\u5e02\u573a\u4e0a\u7684\u5176\u4ed6\u836f\u7269\u8054\u5408\u4f7f\u7528\u3002 \u6eb6\u7624\u7ec6\u80de\u7684\u75c5\u6bd2 2019\u5e74\uff0cImugene\u4eceCity of Hope\u7684Yuman Fong\u6559\u6388\u90a3\u91cc\u83b7\u5f97\u4e86CF33\u6eb6\u7624\u75c5\u6bd2\u5e73\u53f0\u7684\u8bb8\u53ef\u3002 Fong\u6559\u6388\u662f\u8be5\u72ec\u7acb\u7814\u7a76\u673a\u6784\u5916\u79d1\u90e8\u95e8\u7684\u4e3b\u5e2d\u3002\u4ed6\u88ab\u63cf\u8ff0\u4e3a\u4e16\u754c\u77e5\u540d\u7684\u764c\u75c7\u7814\u7a76\u8005\u3001\u5185\u79d1\u533b\u751f\u548c\u5916\u79d1\u533b\u751f\u3002 \u6eb6\u7624\u75c5\u6bd2\u57fa\u672c\u4e0a\u88ab\u8bbe\u8ba1\u6210\u53ea\u611f\u67d3\u548c\u6740\u6b7b\u764c\u7ec6\u80de\u3002\u75c5\u6bd2\u53ef\u4ee5\u8fdb\u4e00\u6b65\u88c5\u5907\u6709\u6548\u8f7d\u8377\uff0c\u4ee5\u63d0\u9ad8\u6740\u4f24\u80fd\u529b\u3002 \u75c5\u6bd2\u8fdb\u5165\u764c\u7ec6\u80de\uff0c\u81ea\u6211\u590d\u5236\uff0c\u6700\u7ec8\u5bfc\u81f4\u7ec6\u80de\u7206\u70b8\u3002\u7136\u540e\uff0c\u6210\u5343\u4e0a\u4e07\u7684\u65b0\u75c5\u6bd2\u9897\u7c92\u91ca\u653e\u5230\u4f53\u5185\uff0c\u5b83\u4eec\u5c06\u5bfb\u627e\u5e76\u6467\u6bc1\u66f4\u591a\u7684\u764c\u7ec6\u80de\u3002 CHECKvacc Imugene\u7684CHECKvacc\u662f\u4e00\u79cd\u6b66\u88c5\u75c5\u6bd2\uff0c\u7531CF33\u3001\u4eba\u7898\u5316\u94a0\u540c\u4f53(hNIS)\u548c\u6297\u4f53aPD-L1\u7ec4\u6210\u3002 \u8fd9\u79cd\u6b66\u88c5\u75c5\u6bd2\u6b63\u7528\u4e8e\u8f6c\u79fb\u6027\u4e09\u9634\u6027\u4e73\u817a\u764c\u60a3\u8005\u7684\u4e00\u671f\u8bd5\u9a8c\u3002 \u5728\u8fd9\u9879\u8bd5\u9a8c\u4e2d\uff0cCHECKvacc\u9776\u5411PD-L1\u86cb\u767d\u5e76\u6fc0\u6d3b\u5c40\u90e8\u80bf\u7624\u5fae\u73af\u5883\u3002 \u4e0a\u5468\uff0cImugene\u62a5\u544a\u4e86CHECKvacc\u7684\u521d\u6b65\u9633\u6027\u6210\u50cf\u6570\u636e\u3002 \u521d\u6b65\u6210\u50cf\u6570\u636e\u663e\u793a\uff0c\u57281\u671f\u4e34\u5e8a\u8bd5\u9a8c\u4e2d\uff0c\u4e09\u4e2a\u961f\u5217\u7684\u4e09\u79cd\u5242\u91cf\u6c34\u5e73\u4e0b\uff0cCHECKvacc\u90fd\u5177\u6709\u201c\u826f\u597d\u7684\u8010\u53d7\u6027\u201d\u3002 \u5ba1\u5224\u4ecd\u5728\u7ee7\u7eed\u3002 \u5728\u4e34\u5e8a\u524d\u7814\u7a76\u4e2d\uff0cCHECKvacc\u663e\u793a\u51fa\u201c\u5f3a\u5927\u7684\u6297\u764c\u6d3b\u6027\u201d\u3002<\/p>\n","protected":false},"author":3,"featured_media":17674,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[3],"tags":[458],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v17.3 (Yoast SEO v21.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Imugene\u4ee51260\u4e07\u6fb3\u5143\u7684\u56de\u6263\u63d0\u5347\u94f6\u884c\u4f59\u989d\uff0c\u7528\u4e8e\u53d1\u5c55\u514d\u75ab\u80bf\u7624\u7597\u6cd5<\/title>\n<meta name=\"description\" content=\"\u5728\u83b7\u5f97\u6fb3\u5927\u5229\u4e9a\u653f\u5e9c1260\u4e07\u6fb3\u5143\u7684\u7814\u53d1\u9000\u7a0e\u540e\uff0cImugene (ASX: IMU)\u6709\u4e86\u66f4\u591a\u7684\u73b0\u91d1\u6765\u7ee7\u7eed\u5176\u514d\u75ab\u80bf\u7624\u7597\u6cd5\u7684\u6301\u7eed\u5f00\u53d1\u3002\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Imugene\u4ee51260\u4e07\u6fb3\u5143\u7684\u56de\u6263\u63d0\u5347\u94f6\u884c\u4f59\u989d\uff0c\u7528\u4e8e\u53d1\u5c55\u514d\u75ab\u80bf\u7624\u7597\u6cd5\" \/>\n<meta property=\"og:description\" content=\"\u5728\u83b7\u5f97\u6fb3\u5927\u5229\u4e9a\u653f\u5e9c1260\u4e07\u6fb3\u5143\u7684\u7814\u53d1\u9000\u7a0e\u540e\uff0cImugene (ASX: IMU)\u6709\u4e86\u66f4\u591a\u7684\u73b0\u91d1\u6765\u7ee7\u7eed\u5176\u514d\u75ab\u80bf\u7624\u7597\u6cd5\u7684\u6301\u7eed\u5f00\u53d1\u3002\" \/>\n<meta property=\"og:url\" content=\"https:\/\/smallcapscn.x5view.co\/imugene-lifts-bank-balance-rebate-progress-immune-oncology-therapies\/\" \/>\n<meta property=\"og:site_name\" content=\"smallcapsCN\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-26T02:08:02+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-29T17:57:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/smallcapscn.x5view.co\/wp-content\/uploads\/2023\/08\/Imugene-ASX-IMU-rebate-progress-immune-oncology-therapies-cancer-RD-tax.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"640\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Lorna Nicholas\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Lorna Nicholas\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/imugene-lifts-bank-balance-rebate-progress-immune-oncology-therapies\/\",\"url\":\"https:\/\/smallcapscn.x5view.co\/imugene-lifts-bank-balance-rebate-progress-immune-oncology-therapies\/\",\"name\":\"Imugene\u4ee51260\u4e07\u6fb3\u5143\u7684\u56de\u6263\u63d0\u5347\u94f6\u884c\u4f59\u989d\uff0c\u7528\u4e8e\u53d1\u5c55\u514d\u75ab\u80bf\u7624\u7597\u6cd5\",\"isPartOf\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\"},\"datePublished\":\"2023-04-26T02:08:02+00:00\",\"dateModified\":\"2023-08-29T17:57:42+00:00\",\"author\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60\"},\"description\":\"\u5728\u83b7\u5f97\u6fb3\u5927\u5229\u4e9a\u653f\u5e9c1260\u4e07\u6fb3\u5143\u7684\u7814\u53d1\u9000\u7a0e\u540e\uff0cImugene (ASX: IMU)\u6709\u4e86\u66f4\u591a\u7684\u73b0\u91d1\u6765\u7ee7\u7eed\u5176\u514d\u75ab\u80bf\u7624\u7597\u6cd5\u7684\u6301\u7eed\u5f00\u53d1\u3002\",\"breadcrumb\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/imugene-lifts-bank-balance-rebate-progress-immune-oncology-therapies\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/smallcapscn.x5view.co\/imugene-lifts-bank-balance-rebate-progress-immune-oncology-therapies\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/imugene-lifts-bank-balance-rebate-progress-immune-oncology-therapies\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/smallcapscn.x5view.co\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Imugene\u4ee51260\u4e07\u6fb3\u5143\u7684\u56de\u6263\u63d0\u5347\u94f6\u884c\u4f59\u989d\uff0c\u7528\u4e8e\u53d1\u5c55\u514d\u75ab\u80bf\u7624\u7597\u6cd5\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\",\"url\":\"https:\/\/smallcapscn.x5view.co\/\",\"name\":\"smallcapsCN\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60\",\"name\":\"Lorna Nicholas\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g\",\"caption\":\"Lorna Nicholas\"},\"description\":\"Lorna has more than 15 years' experience as a business\/finance journalist and editor. She has written for numerous industry publications reporting on various sectors, including: resources, energy, construction, biotech, pharma, science and technology, agriculture, and chemicals. Specialising in resources, Lorna has also covered a myriad of small and large cap ASX and dual-listed stocks.\",\"url\":\"https:\/\/smallcapscn.x5view.co\/?author=3\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Imugene\u4ee51260\u4e07\u6fb3\u5143\u7684\u56de\u6263\u63d0\u5347\u94f6\u884c\u4f59\u989d\uff0c\u7528\u4e8e\u53d1\u5c55\u514d\u75ab\u80bf\u7624\u7597\u6cd5","description":"\u5728\u83b7\u5f97\u6fb3\u5927\u5229\u4e9a\u653f\u5e9c1260\u4e07\u6fb3\u5143\u7684\u7814\u53d1\u9000\u7a0e\u540e\uff0cImugene (ASX: IMU)\u6709\u4e86\u66f4\u591a\u7684\u73b0\u91d1\u6765\u7ee7\u7eed\u5176\u514d\u75ab\u80bf\u7624\u7597\u6cd5\u7684\u6301\u7eed\u5f00\u53d1\u3002","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Imugene\u4ee51260\u4e07\u6fb3\u5143\u7684\u56de\u6263\u63d0\u5347\u94f6\u884c\u4f59\u989d\uff0c\u7528\u4e8e\u53d1\u5c55\u514d\u75ab\u80bf\u7624\u7597\u6cd5","og_description":"\u5728\u83b7\u5f97\u6fb3\u5927\u5229\u4e9a\u653f\u5e9c1260\u4e07\u6fb3\u5143\u7684\u7814\u53d1\u9000\u7a0e\u540e\uff0cImugene (ASX: IMU)\u6709\u4e86\u66f4\u591a\u7684\u73b0\u91d1\u6765\u7ee7\u7eed\u5176\u514d\u75ab\u80bf\u7624\u7597\u6cd5\u7684\u6301\u7eed\u5f00\u53d1\u3002","og_url":"https:\/\/smallcapscn.x5view.co\/imugene-lifts-bank-balance-rebate-progress-immune-oncology-therapies\/","og_site_name":"smallcapsCN","article_published_time":"2023-04-26T02:08:02+00:00","article_modified_time":"2023-08-29T17:57:42+00:00","og_image":[{"width":640,"height":400,"url":"https:\/\/smallcapscn.x5view.co\/wp-content\/uploads\/2023\/08\/Imugene-ASX-IMU-rebate-progress-immune-oncology-therapies-cancer-RD-tax.jpg","type":"image\/jpeg"}],"author":"Lorna Nicholas","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Lorna Nicholas"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/smallcapscn.x5view.co\/imugene-lifts-bank-balance-rebate-progress-immune-oncology-therapies\/","url":"https:\/\/smallcapscn.x5view.co\/imugene-lifts-bank-balance-rebate-progress-immune-oncology-therapies\/","name":"Imugene\u4ee51260\u4e07\u6fb3\u5143\u7684\u56de\u6263\u63d0\u5347\u94f6\u884c\u4f59\u989d\uff0c\u7528\u4e8e\u53d1\u5c55\u514d\u75ab\u80bf\u7624\u7597\u6cd5","isPartOf":{"@id":"https:\/\/smallcapscn.x5view.co\/#website"},"datePublished":"2023-04-26T02:08:02+00:00","dateModified":"2023-08-29T17:57:42+00:00","author":{"@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60"},"description":"\u5728\u83b7\u5f97\u6fb3\u5927\u5229\u4e9a\u653f\u5e9c1260\u4e07\u6fb3\u5143\u7684\u7814\u53d1\u9000\u7a0e\u540e\uff0cImugene (ASX: IMU)\u6709\u4e86\u66f4\u591a\u7684\u73b0\u91d1\u6765\u7ee7\u7eed\u5176\u514d\u75ab\u80bf\u7624\u7597\u6cd5\u7684\u6301\u7eed\u5f00\u53d1\u3002","breadcrumb":{"@id":"https:\/\/smallcapscn.x5view.co\/imugene-lifts-bank-balance-rebate-progress-immune-oncology-therapies\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/smallcapscn.x5view.co\/imugene-lifts-bank-balance-rebate-progress-immune-oncology-therapies\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/smallcapscn.x5view.co\/imugene-lifts-bank-balance-rebate-progress-immune-oncology-therapies\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/smallcapscn.x5view.co\/"},{"@type":"ListItem","position":2,"name":"Imugene\u4ee51260\u4e07\u6fb3\u5143\u7684\u56de\u6263\u63d0\u5347\u94f6\u884c\u4f59\u989d\uff0c\u7528\u4e8e\u53d1\u5c55\u514d\u75ab\u80bf\u7624\u7597\u6cd5"}]},{"@type":"WebSite","@id":"https:\/\/smallcapscn.x5view.co\/#website","url":"https:\/\/smallcapscn.x5view.co\/","name":"smallcapsCN","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60","name":"Lorna Nicholas","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g","caption":"Lorna Nicholas"},"description":"Lorna has more than 15 years' experience as a business\/finance journalist and editor. She has written for numerous industry publications reporting on various sectors, including: resources, energy, construction, biotech, pharma, science and technology, agriculture, and chemicals. Specialising in resources, Lorna has also covered a myriad of small and large cap ASX and dual-listed stocks.","url":"https:\/\/smallcapscn.x5view.co\/?author=3"}]}},"_links":{"self":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/6724"}],"collection":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=6724"}],"version-history":[{"count":1,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/6724\/revisions"}],"predecessor-version":[{"id":20522,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/6724\/revisions\/20522"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/media\/17674"}],"wp:attachment":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=6724"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=6724"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=6724"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}